U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996561) titled 'Exploring the Impact of Genetic Variations on The Clinical Efficacy of Nalbuphine in Postoperative Pain Management' on May 21.
Brief Summary: The goal of this study is to identify the genes as well as their association with Nalbuphine. This will help us identify opioid vulnerability in our population in the postoperative patients and will contribute to overcoming the opioid crisis, resulting in better and safer outcomes.
Research question is:
Is there any association between the underlying genetic variations and the analgesic efficacy of Nalbuphine in postoperative patients? The Research Objectives are
1. To identify the underlyin...